Srikanth Naramala
Srikanth Naramala publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research and Long-Term Effects of COVID-19.
- World rank
- #4,730,268 of 7,710,434 ranked researchers
- Rank in United States
- #1,244,022 of 1,627,098
- Works
- 63
- Citations
- 920
- Citations per work
- 14.6
What does Srikanth Naramala research?
Srikanth Naramala's work is mostly in Medicine (55%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3554.9%
- Medicine3554.9%
- Everything else2845.1%
- 1Infectious Diseases19% of their works
- 2Epidemiology9% of their works
- 3Surgery9% of their works
- 4Rheumatology7% of their works
- 5Neurology7% of their works
- 6Nephrology4% of their works
Research topics
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Long-Term Effects of COVID-19
- Muscle and Compartmental Disorders
- Urticaria and Related Conditions
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Inflammatory Myopathies and Dermatomyositis
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Which keywords describe Srikanth Naramala's research?
The keywords of their largest research topics: ACE2 Receptor, SARS-CoV-2, Pathophysiology, Thrombosis, Clinical Characteristics, Epidemiology, Treatment and Coronavirus.
- Kinin Receptor Family
- Hereditary Angioedema
- Cardiac Amyloidosis
- Chronic Spontaneous Urticaria
- Diagnosis
- Autoantibodies
- Neurologic Manifestations
- Coronavirus
- Epidemiology
- Thrombosis
- SARS-CoV-2
- ACE2 Receptor
- Pathophysiology
- Clinical Characteristics
- Treatment
- Vaccine
- Post-acute COVID-19 Syndrome
- Compartment Syndrome
- Rhabdomyolysis
- Urticaria
- Dermatomyositis
- Inflammatory Myopathies
- Transthyretin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- ACE2 Receptor272 topics
- SARS-CoV-2272 topics
- Pathophysiology222 topics
- Thrombosis182 topics
- Clinical Characteristics151 topic
- Epidemiology151 topic
- Treatment133 topics
- Coronavirus121 topic
- Vaccine121 topic
- Neurologic Manifestations81 topic
- Post-acute COVID-19 Syndrome81 topic
- Autoantibodies72 topics
- Compartment Syndrome71 topic
- Diagnosis72 topics
- Rhabdomyolysis71 topic
- Chronic Spontaneous Urticaria41 topic
- Urticaria41 topic
- Cardiac Amyloidosis31 topic
- Dermatomyositis31 topic
- Hereditary Angioedema31 topic
- Inflammatory Myopathies31 topic
- Kinin Receptor Family31 topic
- Transthyretin31 topic
Where does Srikanth Naramala work?
Srikanth Naramala's main affiliation in the publication record is Adventist HealthCare, United States.
How many publications and citations does Srikanth Naramala have?
OpenAlex counts 63 works and 920 citations for Srikanth Naramala, an h-index of 14, ranking #4,730,268 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Srikanth Naramala. Posts are plain text and can be reported.